U.S. Markets open in 6 hrs 34 mins

INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Aurora Cannabis, Inc., and Zynerba Pharmaceuticals of Filing Deadlines

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of ACB and ZYNE. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. 

To discuss the cases below please contact Matthew E. Guarnero toll free at (877) 779-1414.

Aurora Cannabis Inc.  (ACB)
CLASS PERIOD:
09/11/2019 - 11/14/2019
LEAD PLAINTIFF DEADLINE: January 21, 2020

Defendants failed to disclose to investors that: (1) Aurora's revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) due to the foregoing, defendants' statements about Aurora's receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To get additional information about the Aurora Cannabis Shareholder Class Action contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com

Zynerba Pharmaceuticals  (ZYNE)
CLASS PERIOD:
03/11/2019-09/17/2019
LEAD PLAINTIFF DEADLINE: December 23, 2019

Defendants failed to disclose to investors that: (i) Zygel was proving unsafe and not well-tolerated in the BELIEVE 1 Trial; (ii) the foregoing created a foreseeable, heightened risk that Zynerba would fail to secure the necessary regulatory approvals for commercializing Zygel for the treatment of DEE in children and adolescents; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To get additional information about the Zynerba Shareholder Class Action contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
http://www.bernlieb.com   
(877) 779-1414
MGuarnero@bernlieb.com